ArticleThe Journal of clinical investigation2025
A CD4+ T lymphocyte-specific TCR/GSDMD/IL-2 axis facilitates antitumor immunity.
Yihan Yao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleThe Journal of clinical investigation2025
Yihan Yao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.